Consensus concept of modern effective therapy for Duchenne muscular dystrophy
Authors:
Open Access
- 15 June 2023
- journal article
- research article
- Published by Publishing House ABV Press in Neuromuscular Diseases
- Vol. 13 (2) , 10-19
Abstract
Duchenne muscular dystrophy is a genetic orphan neuromuscular disease caused by a mutation in the DMD gene encoding the protein dystrophin. As a result of developing and progressive muscle damage and atrophy, children lose the ability to walk, develop respiratory and cardiac disorders. The core elements of good care standards are early diagnosis, prevention and treatment of osteoporosis, daily physical therapy, regular rehabilitation, glucocorticosteroids, and control of heart and lung function. The clinical effect of new targeted pathogenetic therapies for Duchenne muscular dystrophy, restoring synthesis of full or truncated dystrophin, depend on their appropriate combination with existing standards of care.Keywords
This publication has 54 references indexed in Scilit:
- THE 6‐minute walk test and other endpoints in Duchenne muscular dystrophy: Longitudinal natural history observations over 48 weeks from a multicenter studyMuscle & Nerve, 2013
- All-Cause Mortality and Cardiovascular Outcomes With Prophylactic Steroid Therapy in Duchenne Muscular DystrophyJACC, 2013
- 25 hydroxyvitamin D serum levels influence adequate response to bisphosphonate treatment in postmenopausal osteoporosisBone, 2012
- The use of intravenous bisphosphonate therapy to treat vertebral fractures due to osteoporosis among boys with Duchenne muscular dystrophyOsteoporosis International, 2012
- Serum 25-hydroxyvitamin D level and acute-phase reaction following initial intravenous bisphosphonateJournal of Bone and Mineral Research, 2010
- Low bone density and bone metabolism alterations in Duchenne muscular dystrophy: response to calcium and vitamin D treatmentOsteoporosis International, 2010
- Glucocorticoid corticosteroids for Duchenne muscular dystrophy2008
- Steroid Therapy and Cardiac Function in Duchenne Muscular DystrophyPediatric Cardiology, 2005
- Severe Hypocalcemia after Intravenous Bisphosphonate Therapy in Occult Vitamin D DeficiencyNew England Journal of Medicine, 2003
- Complete cloning of the duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individualsCell, 1987